New Key Statistics Module, Z-Score and F-Score
XPAR:INFE Key Ratios
Market Cap € M | 71.73 |
Enterprise Value € M | 31.70 |
P/E(ttm) | 11.07 |
PE Ratio without NRI | -- |
Forward PE Ratio | -- |
Price/Book | 1.15 |
Price/Sales | 0.30 |
Price/Free Cash Flow | 4.19 |
Price/Owner Earnings | -- |
Payout Ratio % | 1.30 |
Revenue (TTM) € M | 235.00 |
EPS (TTM) € | 5.51 |
Beneish M-Score | -3.27 |
10-y EBITDA Growth Rate % | 7.50 |
5-y EBITDA Growth Rate % | 28.70 |
y-y EBITDA Growth Rate % | 9.80 |
EV-to-EBIT | 5.77 |
EV-to-EBITDA | 1.41 |
PEG | -- |
Shares Outstanding M | 1.18 |
Net Margin (%) | 2.75 |
Operating Margin % | 0.31 |
Pre-tax Margin (%) | 2.05 |
Quick Ratio | 1.20 |
Current Ratio | 1.21 |
ROA % (ttm) | 2.25 |
ROE % (ttm) | 8.85 |
ROIC % (ttm) | 0.12 |
Dividend Yield % | 11.74 |
Altman Z-Score | 1.16 |
XPAR:INFE Number of Guru Trades
XPAR:INFE Volume of Guru Trades
Gurus Latest Trades with XPAR:INFE
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
XPAR:INFE is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data